Thrombosis of the Abdominal Veins in Childhood

por Kumar, Riten, Kerlin, Bryce A.
Publicado 2017

Protease‐activated receptors: An illustrated review

por Han, Xu, Nieman, Marvin T., Kerlin, Bryce A.
Publicado 2020

Andexanet Alfa Versus Prothrombin Complex Concentrates/Blood Products as Apixaban/Rivaroxaban Reversal Agents: A Survey Among Pediatric Hematologists

por Rodriguez, Vilmarie, Stanek, Joseph, Kerlin, Bryce A., Dunn, Amy L.
Publicado 2022

Plasma Cytokine Profiling to Predict Steroid Resistance in Pediatric Nephrotic Syndrome

por Agrawal, Shipra, Brier, Michael E., Kerlin, Bryce A., Smoyer, William E.
Publicado 2021

Venous thromboembolism in chronic pediatric heart disease is associated with substantial health care burden and expenditures

por Woods, Gary M., Boulet, Sheree L., Texter, Karen, Yates, Andrew R., Kerlin, Bryce A.
Publicado 2019

Decreased Bleeding Rates in Patients with Hemophilia A Switching from Standard-Half-Life FVIII to BAY 94-9027 Prophylaxis

por Mancuso, Maria Elisa, Reding, Mark T., Negrier, Claude, Kerlin, Bryce A., Rangarajan, Savita, Simpson, Mindy L.
Publicado 2021

Development of a Pediatric-Specific Clinical Probability Tool for Diagnosis of Venous Thromboembolism: A Feasibility Study

por Kerlin, Bryce A., Stephens, Julie A., Hogan, Mark J., Smoyer, William E., O'Brien, Sarah H.
Publicado 2014

Drive-Through Anticoagulation Clinic During the COVID-19 Pandemic

por Giver, Jean, Dunn, Amy L., Sankar, Amanda, Stanek, Joseph, Monda, Kay, Canini, Joan, Kerlin, Bryce A., Rodriguez, Vilmarie
Publicado 2022

Nephrotic syndrome‐associated hypercoagulopathy is alleviated by both pioglitazone and glucocorticoid which target two different nuclear receptors

por Waller, Amanda P., Agrawal, Shipra, Wolfgang, Katelyn J., Kino, Jiro, Chanley, Melinda A., Smoyer, William E., Kerlin, Bryce A.
Publicado 2020

Role of protease‐activated receptor‐1 (PAR‐1) in the glomerular filtration barrier integrity

por Medipally, Ajay, Xiao, Min, Biederman, Laura, Satoskar, Anjali A., Ivanov, Iouri, Rovin, Brad, Parikh, Samir, Kerlin, Bryce A., Brodsky, Sergey V.
Publicado 2022

Safety and effectiveness of recombinant factor XIII‐A(2) in congenital factor XIII deficiency: Real‐world evidence

por Poulsen, Lone Hvitfeldt, Kerlin, Bryce A., Castaman, Giancarlo, Molinari, Angelo Claudio, Menegatti, Marzia, Nugent, Diane, Dey, Sohan, Garly, May‐Lill, Carcao, Manuel
Publicado 2022

Recombinant FXIII (rFXIII-A (2) ) Prophylaxis Prevents Bleeding and Allows for Surgery in Patients with Congenital FXIII A-Subunit Deficiency

por Carcao, Manuel, Altisent, Carmen, Castaman, Giancarlo, Fukutake, Katsuyuki, Kerlin, Bryce A., Kessler, Craig, Lassila, Riitta, Nugent, Diane, Oldenburg, Johannes, Garly, May-Lill, Rosholm, Anders, Inbal, Aida
Publicado 2018

Selective modulator of nuclear receptor PPARγ with reduced adipogenic potential ameliorates experimental nephrotic syndrome

por Bryant, Claire, Rask, Galen, Waller, Amanda P., Webb, Amy, Galdino-Pitta, Marina R., Amato, Angelica A., Cianciolo, Rachel, Govindarajan, Rajgopal, Becknell, Brian, Kerlin, Bryce A., Neves, Francisco A.R., Fornoni, Alessia, Agrawal, Shipra
Publicado 2022